Cargando…

RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer

Purpose: This study aims to reveal the relationship between RNA N6-methyladenosine (m6A) regulators and tumor immune microenvironment (TME) in breast cancer, and to establish a risk model for predicting the occurrence and development of tumors. Patients and methods: In the present study, we respecti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mu, Lan-Xin, Shao, You-Cheng, Wei, Lei, Chen, Fang-Fang, Zhang, Jing-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793540/ https://www.ncbi.nlm.nih.gov/pubmed/35095993 http://dx.doi.org/10.3389/fgene.2021.650499

Ejemplares similares

N6-Methyladenosine-Related lncRNAs Are Potential Prognostic Biomarkers and Correlated With Tumor Immune Microenvironment in Osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

N6-Methyladenosine RNA Methylation Regulators Have Clinical Prognostic Values in Hepatocellular Carcinoma
por: Liu, Wei, et al.
Publicado: (2020)

Analysis of N6-Methyladenosine Modification Patterns and Tumor Immune Microenvironment in Pancreatic Adenocarcinoma
por: Liu, Yong, et al.
Publicado: (2022)

RNA N6-Methyladenosine-Related Gene Contribute to Clinical Prognostic Impact on Patients With Liver Cancer
por: Wang, Wei, et al.
Publicado: (2020)

Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma
por: Qi, Li-Wen, et al.
Publicado: (2021)

N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma
por: Maimaiti, Aierpati, et al.
Publicado: (2022)

N6-Methyladenosine-Related lncRNAs Are Novel Prognostic Markers and Predict the Immune Landscape in Acute Myeloid Leukemia
por: Zhang, Lulu, et al.
Publicado: (2022)

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma
por: Zhao, Jianhui, et al.
Publicado: (2021)

Prognostic Characteristics and Immune Effects of N(6)-Methyladenosine and 5-Methylcytosine-Related Regulatory Factors in Clear Cell Renal Cell Carcinoma
por: Li, Lei, et al.
Publicado: (2022)

Gene Signatures and Prognostic Values of N6-Methyladenosine Related Genes in Ovarian Cancer
por: Na, Zhijing, et al.
Publicado: (2021)

N1-methyladenosine methylation-related metabolic genes signature and subtypes for predicting prognosis and immune microenvironment in osteosarcoma
por: Wang, Guowei, et al.
Publicado: (2022)

Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer
por: Gu, Jing, et al.
Publicado: (2021)

N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy
por: Zhang, Meng-Meng, et al.
Publicado: (2021)

Transcriptome-Wide Analysis of RNA N(6)-Methyladenosine Modification in Adriamycin-Resistant Acute Myeloid Leukemia Cells
por: Fang, Shu, et al.
Publicado: (2022)

Analysis of N(6)-Methyladenosine Methylome in Adenocarcinoma of Esophagogastric Junction
por: Huang, Jia-Bin, et al.
Publicado: (2022)

Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
por: Zhu, Qianru, et al.
Publicado: (2022)

Prognostic N6-methyladenosine (m6A)-related lncRNA patterns to aid therapy in pancreatic ductal adenocarcinoma
por: Wang, Yuxin, et al.
Publicado: (2022)

Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

Comprehensive Analysis of N(6)-Methyladenosine (m(6)A) Methylation in Neuromyelitis Optica Spectrum Disorders
por: Yang, Hong, et al.
Publicado: (2021)

Genome-Wide Identification of N(6)-Methyladenosine (m(6)A) SNPs Associated With Rheumatoid Arthritis
por: Mo, Xing-Bo, et al.
Publicado: (2018)

M6AMRFS: Robust Prediction of N6-Methyladenosine Sites With Sequence-Based Features in Multiple Species
por: Qiang, Xiaoli, et al.
Publicado: (2018)

Genomics and Prognosis Analysis of N(6)-Methyladenosine Regulators in Lung Adenocarcinoma
por: Ma, Yanpin, et al.
Publicado: (2021)

Overview of distinct N6-Methyladenosine profiles of messenger RNA in osteoarthritis
por: Yu, Yang, et al.
Publicado: (2023)

Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)

Corrigendum: Distribution Patterns of DNA N6-Methyladenosine Modification in Non-coding RNA Genes
por: Li, Yu, et al.
Publicado: (2020)

Corrigendum: Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)

Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
por: Liu, Qiang
Publicado: (2022)

Novel insight of N(6)-methyladenosine modified subtypes in abdominal aortic aneurysm
por: Wang, Kangjie, et al.
Publicado: (2022)

Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis
por: Zhang, Jingcheng, et al.
Publicado: (2023)

Multifaceted Roles of the N(6)-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment
por: Hu, Chenxi, et al.
Publicado: (2022)

N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer
por: Yu, Lili, et al.
Publicado: (2023)

N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy
por: Guo, Liting, et al.
Publicado: (2021)

N(6)-methyladenosine-modified lncRNA and mRNA modification profiles in cerebral ischemia-reperfusion injury
por: Shao, Le, et al.
Publicado: (2022)

N ( 6 )-Methyladenosine-Related Long Non-Coding RNAs Are Identified as a Potential Prognostic Biomarker for Lung Squamous Cell Carcinoma and Validated by Real-Time PCR
por: Zhang, Wei, et al.
Publicado: (2022)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
por: Wang, Shanshan, et al.
Publicado: (2021)

N6-methyladenosine modulation classes and immune microenvironment regulation in ischemic stroke
por: Tao, Hongmiao, et al.
Publicado: (2022)

Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration
por: Zheng, Guowei, et al.
Publicado: (2022)

m6AGE: A Predictor for N6-Methyladenosine Sites Identification Utilizing Sequence Characteristics and Graph Embedding-Based Geometrical Information
por: Wang, Yan, et al.
Publicado: (2021)

Regulatory role of N(6)-methyladenosine in intramuscular fat deposition in chicken
por: Zhang, Tong, et al.
Publicado: (2023)

YT521-B homology domain family proteins as N6-methyladenosine readers in tumors
por: Yang, Heng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4n4vqfcii3i3fait3thgvtu5d7